Zymeworks (ZYME) Liabilities and Shareholders Equity (2021 - 2023)
Historic Liabilities and Shareholders Equity for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $556.4 million.
- Zymeworks' Liabilities and Shareholders Equity rose 8529.29% to $556.4 million in Q3 2023 from the same period last year, while for Dec 2023 it was $1.8 billion, marking a year-over-year increase of 8537.25%. This contributed to the annual value of $648.7 million for FY2022, which is 6671.08% up from last year.
- According to the latest figures from Q3 2023, Zymeworks' Liabilities and Shareholders Equity is $556.4 million, which was up 8529.29% from $602.1 million recorded in Q2 2023.
- Over the past 5 years, Zymeworks' Liabilities and Shareholders Equity peaked at $648.7 million during Q4 2022, and registered a low of $300.3 million during Q3 2022.
- Its 3-year average for Liabilities and Shareholders Equity is $516.2 million, with a median of $578.6 million in 2023.
- Per our database at Business Quant, Zymeworks' Liabilities and Shareholders Equity soared by 6671.08% in 2022 and then soared by 8529.29% in 2023.
- Quarter analysis of 3 years shows Zymeworks' Liabilities and Shareholders Equity stood at $389.1 million in 2021, then surged by 66.71% to $648.7 million in 2022, then decreased by 14.24% to $556.4 million in 2023.
- Its last three reported values are $556.4 million in Q3 2023, $602.1 million for Q2 2023, and $600.7 million during Q1 2023.